December 17th, 2010
FDA Approves Cryoballoon Ablation Treatment for Paroxysmal AF
Larry Husten, PHD
Medtronic announced today that it has received FDA approval for its Arctic Front® Cardiac CryoAblation Catheter system for the treatment of refractory paroxysmal AF.
One Response to “FDA Approves Cryoballoon Ablation Treatment for Paroxysmal AF”
NEJM Journal Watch — Recent Cardiology Articles- Strategies and Criteria for the Diagnosis and Management of Myocarditis
- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
Probably makes slightly more sense to be more circumspect and careful with an anti-platelet drug which will likely have a much wider clientele than a modality of therapy for paroxysmal resistant afib….